PD-L1 inhibition improves response of pancreatic cancer to radiotherapy

A. Azad, Z. D'Costa, S. Y. Lim, O. Sansom, W. G. McKenna, R. Muschel, E. Fokas

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Article numberOC-0284
Pages (from-to)S133
Number of pages1
JournalRadiotherapy and Oncology
Volume119
Issue numberSupplement 1
DOIs
Publication statusPublished - 2 Apr 2016
Externally publishedYes
EventEuropean Society for Radiotherapy and Oncology - Turin, Italy
Duration: 29 Apr 20163 May 2016

Keywords

  • Programmed cell death 1 receptors
  • Pancreatic cancer treatment
  • Cancer patients
  • Pancreatic cancer
  • Cancer radiotherapy
  • Treatment effectiveness

Cite this

Azad, A., D'Costa, Z., Lim, S. Y., Sansom, O., McKenna, W. G., Muschel, R., & Fokas, E. (2016). PD-L1 inhibition improves response of pancreatic cancer to radiotherapy. Radiotherapy and Oncology, 119(Supplement 1), S133. [OC-0284]. https://doi.org/10.1016/S0167-8140(16)31533-X